Page 9 - Pharmaceutical Firms

Pharma, FMCG push hiring activity in India by 24% in September: Naukri.com

Driven by industries like pharma, fast-moving consumer goods, education and IT, hiring activity in India saw a growth of 24% in September compared to the previous month

Madras HC orders formation of panel to ensure self-reliance in cancer drugs

In its judgment the court said India can not be dependent on China for APIs and ordered the formation of a five member committee to ensure self-reliance

Bank fraud case: 4 Sterling directors declared fugitive economic offenders

A Delhi court on Monday declared four directors of a Gujarat-based pharma firm,Sterling Biotech Ltd (SBL), fugitive economic offenders in a Rs 8,100-crore bank fraud case

Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640

Drug firm Hetero on Friday said it has launched a pack of its generic oral antiviral drug-- Favivir 800/200-- for the treatment of mild-to-moderate symptomatic COVID-19 patients in India.

Higher exports to help pharma eke out 8-9% growth this fiscal: CRISIL

Living up to its moniker of a defensive bet, the Rs 2.8 trn Indian pharmaceutical sector is set to emerge more or less unscathed from the Covid-19 pandemic this fiscal, CRISIL said on Thursday.

India probing alleged dumping of chemical from China, South Korea

In the probe, the directorate will determine the existence, degree and effect of any alleged dumping in respect of the product from China

Pharma companies committed to science-first policy on Covid-19 vaccine

Pharmaceutical companies are committed to a science first approach in the development of COVID-19 vaccines even as the pressure piles on to end the pandemic

Zydus Cadila gets USFDA nod to market mineral supplement tablets

Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement used to treat or prevent low amounts of potassium in the blood

Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks

The next upside for Nifty Pharma is located above the resistance of 12,100 levels.

Gilead to buy cancer drugmaker Immunomedics Inc for $21 billion

Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug

Vaccine majors see sharp rally with some players rising more than 4,000%

The Indian pharmaceutical sector has also been going through a surge

India scaling up production of active pharmaceutical ingredients: Kant

India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to Kant

Pharma sector needs global collaboration: Industry leaders, govt officials

The need of global collaboration in the pharma sector from research and development to drug manufacturing has never been as great as it is now amid the deadly COVID pandemic

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Domestic pharma firms working on new repurposed drug for Covid-19

Advantage over conventional plasma therapy is it will have standard antibodies

R&D for treating Covid-19 by pharmaceutical firms part of CSR activities

Activities undertaken by companies in normal course of business also part of CSR

Pharma to lose pandemic-induced pricing power in Q2 as economies reopen

Pharma companies are unlikely to sustain the healthy operating performance reported in the first quarter as they will lose the margins booked during the global lockdowns

Amazon to launch online drug sales in Bengaluru to enhance reach

Amazon.com Inc said on Friday it will launch an online pharmacy in India that will serve the city of Bengaluru, the latest move by the e-commerce giant to widen its reach in a key growth market

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

Animal pharma Boehringer Ingelheim bets big on pet care segment in India

Boehringer Ingelheim plans to bring innovative products catering mainly to pets and poultry segment in India, as it expects these verticals to grow in a robust manner over the next few years